CN Patent

CN109467538A — 环烯烃取代的杂芳环类化合物及其用途

Assigned to Hutchmed Ltd · Expires 2019-03-15 · 7y expired

What this patent protects

本发明涉及式(I)的环烯烃取代的杂芳环类化合物及其在治疗由IDH突变诱发的疾病中的用途，其中R 1 、R 2 、R 3 、R 3 ’、R 4 、R 4 ’、A、m和n如说明书中所定义。

USPTO Abstract

本发明涉及式(I)的环烯烃取代的杂芳环类化合物及其在治疗由IDH突变诱发的疾病中的用途，其中R 1 、R 2 、R 3 、R 3 ’、R 4 、R 4 ’、A、m和n如说明书中所定义。

Drugs covered by this patent

enasidenib-mesylate (ENASIDENIB MESYLATE)

Patent Metadata

Patent number: CN109467538A
Jurisdiction: CN
Classification: —
Expires: 2019-03-15
Drug substance claim: No
Drug product claim: No
Assignee: Hutchmed Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.